Oral vs intravenous acetaminophen: Which is better for closing a patent ductus arteriosus?
August 2nd 2023In the 18 studies that assessed the efficacy of closing a patent ductus arteriosus after 1 course of acetaminophen treatments, the results demonstrated that both oral and IV preparations were more effective than placebo.
FDA, DEA address public on prescription stimulant medication shortages
August 1st 2023In a letter addressed to the public, the FDA and Drug Enforcement Agency stated that prescription stimulant drug shortages are impacting patients and their families The agencies are taking a multifaceted approach to mitigate these shortages and find potential solutions.
American Academy of Pediatrics’ guidance for organ donation and transplantation
August 1st 2023Updated guidance for pediatricians that interact with children and their families, who need a potentially life-saving organ donation or transplantation, has been released by the American Academy of Pediatrics (AAP).
Contemporary Pediatrics most-viewed articles from April to July, 2023
August 1st 2023In this review article, take a look back at the top-performing stories from Contemporary Pediatrics from April to August 2023. With each article highlighted below, you’ll find updated news and notes along with a quick recap and direct link to our most-viewed articles.
What skepticism is there regarding advanced atopic dermatitis treatment options?
July 28th 2023Peter Lio, MD, clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine in Chicago, Illinois, discusses the 2023 Society for Pediatric Dermatology Meeting held in Asheville, North Carolina, and what pearls to consider following the atopic dermatitis panel he took part in.
Study: COVID-19 diagnosis associated with increased incidence of type 1 diabetes
July 28th 2023Further studies are needed to determine if vaccination should be considered in children at risk for type 1 diabetes (T1D), as a COVID-19 diagnosis among children was associated with an increased incidence of T1D, according to a recent study.
Increased reimbursement could Improve HPV vaccination rates, study finds
July 27th 2023An analysis of a nationwide sample of more than 30,000 clinicians provides insight into rates of HPV vaccination among US adolescents and how changes in reimbursement rate might encourage increased vaccination rates.
How breast milk antibodies impact infant immunity
July 26th 2023Timothy Hand, PhD, associate professor of pediatrics and immunology at the University of Pittsburgh School of Medicine and UPMC Children’s Hospital of Pittsburgh, discusses how antibodies provided from breast milk can improve immunity in infants.
USPSTF issues statement on speech, language disorder screenings for all children up to 5 years
July 26th 2023Due to a lack of evidence, the US Preventive Services Task Force (USPSTF) did not make a recommendation for or against screening for speech and delay disorder in all children 5 years or younger by primary health care professionals.
Axatilimab meets primary outcome in phase 2 chronic graft versus host disease trial
July 25th 2023Results from a pivotal phase 2 clinical trial revealed axatilimab met the primary outcome in all cohorts for graft versus host disease (GVHD) in pediatric and adult patients. Based on its safety and efficacy profile demonstrated in clinical trials, Syndax and Incyte intend to file a biologics license application (BLA) for axatilimab with the FDA by the end of 2023.
Masters of pediatric dermatology course offered to healthcare providers
July 25th 2023The fully online training program, the MOPD Foundations of Pediatric Dermatology Certificate Course, was created by the founders of the Masters of Pediatric Dermatology (MOPD) Symposium and includes lectures, presentations, and downloadable resources for clinicians.
American Indian and Alaska Native children experience high rates of RSV-related hospitalizations
July 24th 2023Results from this active, facility-based surveillance study revealed hospitalization rates for children younger than 5 years were 1.7 to 7.1 times higher among American Indian and Alaska Native children compared to estimates from the methodologically similar US New Vaccine Surveillance Network (NVSN).
Pfizer announces phase 2 data of Group B Streptococcus vaccine candidate
July 20th 2023According to Pfizer, the investigational vaccine to protect against Group B Streptococcus (GBS) generated maternal antibody responses against 6 capsular polysaccharide serotypes and efficiently transferred antibodies to the infants. The announcement of this phase 2 data comes in July, which is International Group B Streptococcus Month.
Prehospital medication dosing deviates from recommended weight-based guidelines
July 20th 2023Lorazepam, diazepam, midazolam, fentanyl, hydromorphone, morphine, ketorolac, epinephrine, diphenhydramine, and methylprednisolone were investigated in the study. Overall, the most common type of deviation was an underdose.
Rise in pediatric diabetes cases continued through year 2 of COVID-19 pandemic
July 20th 2023A follow-up to an earlier study, the latest research leveraged EHR data from medical centers in North Carolina and concluded incident cases of type 1 diabetes increased nearly 50% and incident cases of type 2 diabetes more than doubled in 2021-2022 relative to prepandemic years.